Omics! Omics!

Somewhere in life I've heard a children's/novelty song about a one ton tomato; eventually (if I remember correctly) it ends up as a ...

The Globe this week had a number of articles on the passing of the $1B biotech bill in Massachusetts and the proxy fight for Biogen Idec. B...

The Next Generation & I went to the Boston Museum of Science today (we're members this year) and one of the exhibits where he linger...

Twice in the last week the Globe has run pieces on a concept called 'The Great Filter', once on the Op-Ed page and now in the Star W...

While searching Amazon for a book, I came across a very funny (in a geeky way) line of plush toys: all sorts of microbes! GiantMicrobes.com...

I don't watch a lot of network television, but there are a handful of programs that have latched onto me. At the end of this season, th...

Last week's Globe carried an item that a real estate firm is planning a 5-year, $1 billion dollar, 1.5M square foot biotech complex in C...

My one previous foray into social networking sites was LinkedIn. During one of MLNM's scythe-to-the-workforce exercises folks started s...

Tuesday morning's Globe carries a front page item, with the headline above the fold, outlining the wayward course which Governor Patrick...

A nice item in GenomeWeb about a new NIH initiative that's just brilliant -- using omics to try to solve rare disease mysteries. I...

Yesterday was Mother's Day, and while searching for a card I spied what looked like a double helix on the front of one card. Finding th...

Either Science or Nature (I can't find the item now) had a blurb noting that a Chilean observatory will play a prominent role in an upco...

In case it hasn't been obvious from the occasional post, I am a spaceflight aficionado. As a very young child I watched some of the las...

In general I try to ignore the various bleatings of stock pickers. Given the mountain of evidence in favor of the efficient market hypothes...

On a more scientific and interesting note, a n ew paper in Nature reports on what happens to E.coli if you mess with its regulatory network...

With depressing predictability, the Takeda purchase offer of Millennium has been followed by the filing of a shareholder lawsuit claiming th...

Okay, a day of reflection, buzz -- and two articles in the Boston Globe on the Millennium buyout. One leads from the front page & is a ...

Boy, if today's news can't break me out of my blogging neglect, then nothing can. Japanese pharma Takeda is buying my old shop for ...

My print version of Science showed up and the cover looks more like some foodie rag. I guessed wrong at first that they were peppers -- ri...